{"top_spans": [[0, 0], [2, 2], [4, 7], [4, 11], [9, 11], [9, 13], [9, 14], [13, 13], [13, 14], [16, 23], [20, 23], [21, 23], [23, 23], [25, 25], [27, 27], [33, 33], [34, 35], [34, 37], [37, 37], [39, 39], [48, 48], [48, 50], [56, 57]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 5, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["novartis", "is", "going", "after", "a", "5", "billion", "market", "with", "a", "new", "treatment", "for", "vision", "loss", "that", "a", "big", "threat", "to", "regeneron", "novartis", "drug", "brolucizumab", "just", "showed", "that", "it", "was", "n't", "any", "worse", "than", "eylea", "a", "drug", "from", "regeneron", "at", "treating", "an", "eye", "disease", "5", "billion", "novartis", "vision", "loss", "business", "insider", "eylea", "amd", "regeneron", "american", "academy", "of", "ophthalmology", "vision"], "clusters": [[[13, 14], [27, 27]]]}